Medicare Prescription Drug Price Negotiation Act of 2021
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Mar 18, 2021)
Medicare Prescription Drug Price Negotiation Act of 2021
This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.
What just happenedMar 19, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseMar 18, 2021
- Mar 19, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 18, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 18, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Mar 18, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Mar 18, 2021IntroReferralIntro-H
Introduced in House
- Mar 18, 2021IntroReferral1000
Introduced in House